Cargando…
1,4-Naphthoquinone (CNN1) Induces Apoptosis through DNA Damage and Promotes Upregulation of H2AFX in Leukemia Multidrug Resistant Cell Line
The multidrug resistance (MDR) phenotype is one of the major obstacles in the treatment of chronic myeloid leukemia (CML) in advantage stages such as blast crisis. In this scenario, more patients develop resistance mechanisms during the course of the disease, making tyrosine kinase inhibitors (TKIs)...
Autores principales: | de Sousa Portilho, Adrhyann Jullyanne, da Silva, Emerson Lucena, Bezerra, Emanuel Cintra Austregésilo, Moraes Rego Gomes, Carinne Borges de Souza, Ferreira, Vitor, de Moraes, Maria Elisabete Amaral, da Rocha, David Rodrigues, Burbano, Rommel Mário Rodriguez, Moreira-Nunes, Caroline Aquino, Montenegro, Raquel Carvalho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330061/ https://www.ncbi.nlm.nih.gov/pubmed/35897681 http://dx.doi.org/10.3390/ijms23158105 |
Ejemplares similares
-
Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia
por: Moreira-Nunes, Caroline Aquino, et al.
Publicado: (2020) -
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
por: Machado, Caio Bezerra, et al.
Publicado: (2021) -
Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer
por: Mesquita, Felipe Pantoja, et al.
Publicado: (2022) -
Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action
por: Daniel, Julio Paulino, et al.
Publicado: (2022) -
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution
por: de Pinho Pessoa, Flávia Melo Cunha, et al.
Publicado: (2022)